Angiogenesis in autosomal-dominant polycystic kidney disease
- 1 July 2001
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 60 (1), 37-45
- https://doi.org/10.1046/j.1523-1755.2001.00768.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitorKidney International, 2000
- Time to treat polycystic kidney diseases like the neoplastic disorders that they areKidney International, 2000
- Role of vascular endothelial growth factor in the regulation of angiogenesisKidney International, 1999
- Increased Expression of KDR/Flk-1 (VEGFR-2) in Murine Model of Ischemia-Induced Retinal NeovascularizationMicrovascular Research, 1998
- Antiangiogenic tumour therapy: will it work?Trends in Pharmacological Sciences, 1998
- Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3Cell, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Taxol inhibits progression of congenital polycystic kidney diseaseNature, 1994
- Effects of angiotensin converting enzyme inhibition in adult polycystic kidney diseaseKidney International, 1992
- The anatomy of the renin-secreting cell in adult polycystic kidney diseaseKidney International, 1988